Qube Research & Technologies (QRT)
OMGA

Qube Research & Technologies (QRT)’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-36,742
Closed -$222K – 3141
2023
Q1 		$222K Buy
36,742
+15,421
+72% +$107K ﹤0.01% 1895
2022
Q4 		$122K Buy
21,321
+9,703
+84% +$54.5K ﹤0.01% 1954
2022
Q3 		$63K Sell
11,618
-2,001
-15% -$10.1K ﹤0.01% 2091
2022
Q2 		$52K Buy
+13,619
New +$50.7K ﹤0.01% 2120

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OMGA Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2023, closing a stake of 36,742 shares — an estimated $222K sold.

Qube Research & Technologies (QRT) first reported a position in OMGA in Q2 2022 and held it in 4 quarters. The position peaked at $222K in Q1 2023. 58 funds tracked by Wall St. Rank hold OMGA as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 36,742 Omega Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $222K.
  • Qube Research & Technologies (QRT) first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s Omega Therapeutics, Inc. Common Stock position peaked at $222K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.